{"filing":{"accession_number":"0001493152-26-031375","cik":"0001757499","ticker":"SHPH","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","form":"8-K","filing_date":"2026-06-30","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1757499/000149315226031375/form8-k.htm"},"events":[{"id":15192,"run_id":13559,"accession_number":"0001493152-26-031375","anchor_item_number":"8.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"The 8-K discloses Shuttle Pharmaceuticals' acquisition of United Dogecoin Inc., a Dogecoin mining and digital infrastructure company. The press releases (Exhibits 99.1 and 99.2) describe United Dogecoin as \"recently acquired by Shuttle Pharmaceutical Holdings, Inc.\" and detail post-acquisition operational milestones including miner purchases, data centre site acquisition, and infrastructure strategy. This represents a material change of control and business combination that would significantly affect investor assessment of Shuttle's strategic direction and asset base.","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","ticker":"SHPH","filing_date":"2026-06-30","form":"8-K","submitted_at":null,"items":[{"id":12870,"accession_number":"0001493152-26-031375","item_number":"8.01","item_title":"of this Current Report on Form 8-K may contain “forward-looking statements.” Such statements which are not purely","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The 8-K discloses Shuttle Pharmaceuticals' acquisition of United Dogecoin Inc., a Dogecoin mining and digital infrastructure company. The press releases (Exhibits 99.1 and 99.2) describe United Dogecoin as \"recently acquired by Shuttle Pharmaceutical Holdings, Inc.\" and detail post-acquisition operational milestones including miner purchases, data centre site acquisition, and infrastructure strategy. This represents a material change of control and business combination that would significantly affect investor assessment of Shuttle's strategic direction and asset base.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:22:01.697374+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":12870,"accession_number":"0001493152-26-031375","item_number":"8.01","item_title":"of this Current Report on Form 8-K may contain “forward-looking statements.” Such statements which are not purely","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The 8-K discloses Shuttle Pharmaceuticals' acquisition of United Dogecoin Inc., a Dogecoin mining and digital infrastructure company. The press releases (Exhibits 99.1 and 99.2) describe United Dogecoin as \"recently acquired by Shuttle Pharmaceutical Holdings, Inc.\" and detail post-acquisition operational milestones including miner purchases, data centre site acquisition, and infrastructure strategy. This represents a material change of control and business combination that would significantly affect investor assessment of Shuttle's strategic direction and asset base.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T11:22:01.697374+00:00","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","ticker":"SHPH","filing_date":"2026-06-30"}]}